Oncotarget

Research Papers:

Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma

Hiroaki Nagata, Ken-Ichi Kozaki, Tomoki Muramatsu, Hidekazu Hiramoto, Kousuke Tanimoto, Naoto Fujiwara, Seiya Imoto, Daisuke Ichikawa, Eigo Otsuji, Satoru Miyano, Tatsuyuki Kawano and Johji Inazawa _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:37740-37750. https://doi.org/10.18632/oncotarget.17147

Metrics: PDF 2389 views  |   HTML 2715 views  |   ?  


Abstract

Hiroaki Nagata1,6, Ken-Ichi Kozaki1,2,8, Tomoki Muramatsu1, Hidekazu Hiramoto1,6, Kousuke Tanimoto4, Naoto Fujiwara1,5, Seiya Imoto7, Daisuke Ichikawa6, Eigo Otsuji6, Satoru Miyano7, Tatsuyuki Kawano5 and Johji Inazawa1,2,3

1Department of Molecular Cytogenetics, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan

2Hard Tissue Genome Research Center, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan

3Bioresource Research Center, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan

4Genome Laboratory, Graduate School of Medicine, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan

5Department of Esophageal and General Surgery, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan

6Department of Digestive Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan

7Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan

8Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Kita-ku, Okayama, Japan

Correspondence to:

Johji Inazawa, email: [email protected]

Keywords: esophageal squamous cell carcinoma, DNA methylation, predictive biomarker, lymph node metastasis, pyrosequencing analysis

Received: June 16, 2016     Accepted: March 28, 2017     Published: April 17, 2017

ABSTRACT

Lymph node metastasis (LNM) of esophageal squamous cell carcinoma (ESCC) is well-known to be an early event associated with poor prognosis in patients with ESCC. Recently, tumor-specific aberrant DNA methylation of CpG islands around the promoter regions of tumor-related genes has been investigated as a possible biomarker for use in early diagnosis and prediction of prognosis. However, there are few DNA methylation markers able to predict the presence of LNM in ESCC. To identify DNA methylation markers associated with LNM of ESCC, we performed a genome-wide screening of DNA methylation status in a discovery cohort of 67 primary ESCC tissues and their paired normal esophageal tissues using the Illumina Infinium HumanMethylation450 BeadChip. In this screening, we focused on differentially methylated regions (DMRs) that were associated with LNM of ESCC, as prime candidates for DNA methylation markers. We extracted three genes, HOXB2, SLC15A3, and SEPT9, as candidates predicting LNM of ESCC, using pyrosequencing and several statistical analyses in the discovery cohort. We confirmed that HOXB2 and SEPT9 were highly methylated in LNM-positive tumors in 59 ESCC validation samples. These results suggested that HOXB2 and SEPT9 may be useful epigenetic biomarkers for the prediction of the presence of LNM in ESCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17147